APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Microneedle Flu Vaccine Market Analysis and Forecast 2026-2032

30 December 2025197 pages

Choose your research edition.

Industry ResearchMicroneedle Flu Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Flu Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Microneedle Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Flu Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Flu Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Microneedle Flu Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Microneedle Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microneedle Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microneedle Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microneedle Flu Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Microneedle Flu Vaccine include Sanofi, NanoPass Technologies, Microdermics and OraSure Technologies, GC Pharma, FluGen, Debiotech, CosMED Pharmaceuticals, Corium International and Becton Dickinson and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Microneedle Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microneedle Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Microneedle Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microneedle Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microneedle Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Microneedle Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.

Microneedle Flu Vaccine Segment by Company

Sanofi

NanoPass Technologies

Microdermics and OraSure Technologies

GC Pharma

FluGen

Debiotech

CosMED Pharmaceuticals

Corium International

Becton Dickinson and Company

Microneedle Flu Vaccine Segment by Type

Hollow Microneedle

Coated Microneedle

Solid Microneedle

Dissolving Microneedle

Microneedle Flu Vaccine Segment by Application

Influenza A

Influenza B

Microneedle Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Microneedle Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microneedle Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microneedle Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hollow Microneedle Major Manufacturers Table 3. Coated Microneedle Major Manufacturers Table 4. Solid Microneedle Major Manufacturers Table 5. Dissolving Microneedle Major Manufacturers Table 6. Global Microneedle Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Influenza A Major Manufacturers Table 8. Influenza B Major Manufacturers Table 9. Microneedle Flu Vaccine Industry Trends Table 10. Microneedle Flu Vaccine Industry Drivers Table 11. Microneedle Flu Vaccine Industry Opportunities and Challenges Table 12. Microneedle Flu Vaccine Industry Restraints Table 13. Global Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Microneedle Flu Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Microneedle Flu Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Microneedle Flu Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Microneedle Flu Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Microneedle Flu Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 20. Global Microneedle Flu Vaccine Sales by Region (2027-2032) & (K Units) Table 21. Global Microneedle Flu Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Microneedle Flu Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Microneedle Flu Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Microneedle Flu Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Microneedle Flu Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Microneedle Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Microneedle Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Microneedle Flu Vaccine Manufacturers, Product Type & Application Table 31. Global Microneedle Flu Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Microneedle Flu Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Microneedle Flu Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Microneedle Flu Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Microneedle Flu Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 41. Global Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 42. Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Microneedle Flu Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Microneedle Flu Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Microneedle Flu Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Microneedle Flu Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Microneedle Flu Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Microneedle Flu Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 54. Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Microneedle Flu Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Microneedle Flu Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Microneedle Flu Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sanofi Microneedle Flu Vaccine Product Portfolio Table 62. Sanofi Recent Development Table 63. NanoPass Technologies Company Information Table 64. NanoPass Technologies Business Overview Table 65. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. NanoPass Technologies Microneedle Flu Vaccine Product Portfolio Table 67. NanoPass Technologies Recent Development Table 68. Microdermics and OraSure Technologies Company Information Table 69. Microdermics and OraSure Technologies Business Overview Table 70. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio Table 72. Microdermics and OraSure Technologies Recent Development Table 73. GC Pharma Company Information Table 74. GC Pharma Business Overview Table 75. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GC Pharma Microneedle Flu Vaccine Product Portfolio Table 77. GC Pharma Recent Development Table 78. FluGen Company Information Table 79. FluGen Business Overview Table 80. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. FluGen Microneedle Flu Vaccine Product Portfolio Table 82. FluGen Recent Development Table 83. Debiotech Company Information Table 84. Debiotech Business Overview Table 85. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Debiotech Microneedle Flu Vaccine Product Portfolio Table 87. Debiotech Recent Development Table 88. CosMED Pharmaceuticals Company Information Table 89. CosMED Pharmaceuticals Business Overview Table 90. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio Table 92. CosMED Pharmaceuticals Recent Development Table 93. Corium International Company Information Table 94. Corium International Business Overview Table 95. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Corium International Microneedle Flu Vaccine Product Portfolio Table 97. Corium International Recent Development Table 98. Becton Dickinson and Company Company Information Table 99. Becton Dickinson and Company Business Overview Table 100. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio Table 102. Becton Dickinson and Company Recent Development Table 103. North America Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 106. North America Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 107. North America Microneedle Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 108. North America Microneedle Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 109. North America Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 112. North America Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 113. North America Microneedle Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 114. North America Microneedle Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 115. North America Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Microneedle Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Microneedle Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 119. North America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 120. North America Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 121. North America Microneedle Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 122. North America Microneedle Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 123. United States Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Canada Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 125. Europe Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 128. Europe Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 129. Europe Microneedle Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 130. Europe Microneedle Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 131. Europe Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 134. Europe Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 135. Europe Microneedle Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 136. Europe Microneedle Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Europe Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Microneedle Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Microneedle Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 141. Europe Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 142. Europe Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 143. Europe Microneedle Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 144. Europe Microneedle Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 145. Germany Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 146. France Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 147. U.K. Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Italy Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Netherlands Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 150. China Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 151. China Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 152. China Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 153. China Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 154. China Microneedle Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China Microneedle Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. China Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. China Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 159. China Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 160. China Microneedle Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China Microneedle Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 165. Asia Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 166. Asia Microneedle Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia Microneedle Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 171. Asia Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 172. Asia Microneedle Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia Microneedle Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Microneedle Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Microneedle Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. Asia Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 179. Asia Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 180. Asia Microneedle Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia Microneedle Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 183. South Korea Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 184. India Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Australia Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 186. China Taiwan Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Microneedle Flu Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Microneedle Flu Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 191. SAMEA Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 192. SAMEA Microneedle Flu Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA Microneedle Flu Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA Microneedle Flu Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Microneedle Flu Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 197. SAMEA Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 198. SAMEA Microneedle Flu Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA Microneedle Flu Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Microneedle Flu Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Microneedle Flu Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. SAMEA Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 205. SAMEA Microneedle Flu Vaccine Sales by Country (2027-2032) & (K Units) Table 206. SAMEA Microneedle Flu Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA Microneedle Flu Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Argentina Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Chile Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Colombia Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Peru Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Israel Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 215. UAE Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Turkey Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Iran Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Egypt Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Microneedle Flu Vaccine Distributors List Table 222. Microneedle Flu Vaccine Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Microneedle Flu Vaccine Image Figure 2. Global Microneedle Flu Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hollow Microneedle Image Figure 5. Coated Microneedle Image Figure 6. Solid Microneedle Image Figure 7. Dissolving Microneedle Image Figure 8. Global Microneedle Flu Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Microneedle Flu Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Influenza A Image Figure 11. Influenza B Image Figure 12. Global Microneedle Flu Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Microneedle Flu Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Microneedle Flu Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Microneedle Flu Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Microneedle Flu Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Microneedle Flu Vaccine Sales (2021-2032) & (K Units) Figure 18. Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Microneedle Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Microneedle Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. China Microneedle Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Microneedle Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Microneedle Flu Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Global Microneedle Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Microneedle Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Microneedle Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Microneedle Flu Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Microneedle Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Microneedle Flu Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Microneedle Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Microneedle Flu Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Microneedle Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Microneedle Flu Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Microneedle Flu Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Microneedle Flu Vaccine Sales Share by Type (2021-2032) Figure 42. North America Microneedle Flu Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Microneedle Flu Vaccine Sales Share by Application (2021-2032) Figure 44. North America Microneedle Flu Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Microneedle Flu Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Microneedle Flu Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Microneedle Flu Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Microneedle Flu Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Microneedle Flu Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Microneedle Flu Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Microneedle Flu Vaccine Sales Share by Country (2021-2032) Figure 52. China Microneedle Flu Vaccine Revenue Share by Type (2021-2032) Figure 53. China Microneedle Flu Vaccine Sales Share by Type (2021-2032) Figure 54. China Microneedle Flu Vaccine Revenue Share by Application (2021-2032) Figure 55. China Microneedle Flu Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Microneedle Flu Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Microneedle Flu Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Microneedle Flu Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Microneedle Flu Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Microneedle Flu Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Microneedle Flu Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Microneedle Flu Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Microneedle Flu Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Microneedle Flu Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Microneedle Flu Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Microneedle Flu Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Microneedle Flu Vaccine Sales Share by Country (2021-2032) Figure 68. Microneedle Flu Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Microneedle Flu Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle
  • Coated Microneedle
  • Solid Microneedle
  • Dissolving Microneedle
Applications
  • Influenza A
  • Influenza B
Companies covered
  • Sanofi
  • NanoPass Technologies
  • Microdermics and OraSure Technologies
  • GC Pharma
  • FluGen
  • Debiotech
  • CosMED Pharmaceuticals
  • Corium International
  • Becton Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microneedle Flu Vaccine Market by Type
  3. 1.2.1 Global Microneedle Flu Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hollow Microneedle
  5. 1.2.3 Coated Microneedle
  6. 1.2.4 Solid Microneedle
  7. 1.2.5 Dissolving Microneedle
  8. 1.3 Microneedle Flu Vaccine Market by Application
  9. 1.3.1 Global Microneedle Flu Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Influenza A
  11. 1.3.3 Influenza B
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Microneedle Flu Vaccine Market Dynamics
  1. 2.1 Microneedle Flu Vaccine Industry Trends
  2. 2.2 Microneedle Flu Vaccine Industry Drivers
  3. 2.3 Microneedle Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Microneedle Flu Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Microneedle Flu Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Microneedle Flu Vaccine Revenue by Region
  3. 3.2.1 Global Microneedle Flu Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microneedle Flu Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Microneedle Flu Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Microneedle Flu Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Microneedle Flu Vaccine Sales by Region
  9. 3.4.1 Global Microneedle Flu Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Microneedle Flu Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Microneedle Flu Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Microneedle Flu Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Microneedle Flu Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Microneedle Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microneedle Flu Vaccine Sales by Manufacturers
  6. 4.2.1 Global Microneedle Flu Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Microneedle Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Microneedle Flu Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Microneedle Flu Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Microneedle Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Microneedle Flu Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Microneedle Flu Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Microneedle Flu Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Microneedle Flu Vaccine Tier 1, Tier 2, and Tier 3
5 Microneedle Flu Vaccine Market by Type
  1. 5.1 Global Microneedle Flu Vaccine Revenue by Type
  2. 5.1.1 Global Microneedle Flu Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Microneedle Flu Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Microneedle Flu Vaccine Sales by Type
  6. 5.2.1 Global Microneedle Flu Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microneedle Flu Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Microneedle Flu Vaccine Price by Type
6 Microneedle Flu Vaccine Market by Application
  1. 6.1 Global Microneedle Flu Vaccine Revenue by Application
  2. 6.1.1 Global Microneedle Flu Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Microneedle Flu Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Microneedle Flu Vaccine Sales by Application
  6. 6.2.1 Global Microneedle Flu Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Microneedle Flu Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Microneedle Flu Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 NanoPass Technologies
  8. 7.2.1 NanoPass Technologies Company Information
  9. 7.2.2 NanoPass Technologies Business Overview
  10. 7.2.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
  12. 7.2.5 NanoPass Technologies Recent Developments
  13. 7.3 Microdermics and OraSure Technologies
  14. 7.3.1 Microdermics and OraSure Technologies Company Information
  15. 7.3.2 Microdermics and OraSure Technologies Business Overview
  16. 7.3.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
  18. 7.3.5 Microdermics and OraSure Technologies Recent Developments
  19. 7.4 GC Pharma
  20. 7.4.1 GC Pharma Company Information
  21. 7.4.2 GC Pharma Business Overview
  22. 7.4.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
  24. 7.4.5 GC Pharma Recent Developments
  25. 7.5 FluGen
  26. 7.5.1 FluGen Company Information
  27. 7.5.2 FluGen Business Overview
  28. 7.5.3 FluGen Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 FluGen Microneedle Flu Vaccine Product Portfolio
  30. 7.5.5 FluGen Recent Developments
  31. 7.6 Debiotech
  32. 7.6.1 Debiotech Company Information
  33. 7.6.2 Debiotech Business Overview
  34. 7.6.3 Debiotech Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Debiotech Microneedle Flu Vaccine Product Portfolio
  36. 7.6.5 Debiotech Recent Developments
  37. 7.7 CosMED Pharmaceuticals
  38. 7.7.1 CosMED Pharmaceuticals Company Information
  39. 7.7.2 CosMED Pharmaceuticals Business Overview
  40. 7.7.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
  42. 7.7.5 CosMED Pharmaceuticals Recent Developments
  43. 7.8 Corium International
  44. 7.8.1 Corium International Company Information
  45. 7.8.2 Corium International Business Overview
  46. 7.8.3 Corium International Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Corium International Microneedle Flu Vaccine Product Portfolio
  48. 7.8.5 Corium International Recent Developments
  49. 7.9 Becton Dickinson and Company
  50. 7.9.1 Becton Dickinson and Company Company Information
  51. 7.9.2 Becton Dickinson and Company Business Overview
  52. 7.9.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
  54. 7.9.5 Becton Dickinson and Company Recent Developments
8 North America
  1. 8.1 North America Microneedle Flu Vaccine Market Size by Type
  2. 8.1.1 North America Microneedle Flu Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Microneedle Flu Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Microneedle Flu Vaccine Price by Type (2021-2032)
  5. 8.2 North America Microneedle Flu Vaccine Market Size by Application
  6. 8.2.1 North America Microneedle Flu Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Microneedle Flu Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Microneedle Flu Vaccine Price by Application (2021-2032)
  9. 8.3 North America Microneedle Flu Vaccine Market Size by Country
  10. 8.3.1 North America Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Microneedle Flu Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Microneedle Flu Vaccine Market Size by Type
  2. 9.1.1 Europe Microneedle Flu Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Microneedle Flu Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Microneedle Flu Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Microneedle Flu Vaccine Market Size by Application
  6. 9.2.1 Europe Microneedle Flu Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Microneedle Flu Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Microneedle Flu Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Microneedle Flu Vaccine Market Size by Country
  10. 9.3.1 Europe Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Microneedle Flu Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Microneedle Flu Vaccine Market Size by Type
  2. 10.1.1 China Microneedle Flu Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Microneedle Flu Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Microneedle Flu Vaccine Price by Type (2021-2032)
  5. 10.2 China Microneedle Flu Vaccine Market Size by Application
  6. 10.2.1 China Microneedle Flu Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Microneedle Flu Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Microneedle Flu Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microneedle Flu Vaccine Market Size by Type
  2. 11.1.1 Asia Microneedle Flu Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Microneedle Flu Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Microneedle Flu Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Microneedle Flu Vaccine Market Size by Application
  6. 11.2.1 Asia Microneedle Flu Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Microneedle Flu Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Microneedle Flu Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Microneedle Flu Vaccine Market Size by Country
  10. 11.3.1 Asia Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Microneedle Flu Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microneedle Flu Vaccine Market Size by Type
  2. 12.1.1 SAMEA Microneedle Flu Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Microneedle Flu Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Microneedle Flu Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Microneedle Flu Vaccine Market Size by Application
  6. 12.2.1 SAMEA Microneedle Flu Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Microneedle Flu Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Microneedle Flu Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Microneedle Flu Vaccine Market Size by Country
  10. 12.3.1 SAMEA Microneedle Flu Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Microneedle Flu Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Microneedle Flu Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Microneedle Flu Vaccine Value Chain Analysis
  2. 13.1.1 Microneedle Flu Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Microneedle Flu Vaccine Production Mode & Process
  6. 13.2 Microneedle Flu Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Microneedle Flu Vaccine Distributors
  9. 13.2.3 Microneedle Flu Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst